Evidence map›Paper›PMID 32499401›Full record

ArticleGenes & development2020

Competition between maturation and degradation drives human snRNA 3' end quality control.

Rea M Lardelli, Jens Lykke-Andersen

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sm complex assembly and 5' cap trimethylation promote selective processing of snRNAs by the 3' exonuclease TOE1.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rea M LardelliDivision of Biological Sciences, University of California San Diego, La Jolla, California 92093, USA.
Jens Lykke-AndersenDivision of Biological Sciences, University of California San Diego, La Jolla, California 92093, USA.
University of California, San Diego · US

Funding

Mechanisms of human RNA turnover and quality controlR35GM118069 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LYKKE-ANDERSEN, JENS · 2016 to 2025
$5.1M
What is the molecular function of MOV10 ATPase in RNA-induced silencing of mRNA?F32GM106706 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LARDELLI, REA M · 2013 to 2014
$107k
NIGMS NIH HHS F32 GM106706NIGMS NIH HHS R35 GM118069
6 · The paper itself

Abstract

Polymerases and exonucleases act on 3' ends of nascent RNAs to promote their maturation or degradation but how the balance between these activities is controlled to dictate the fates of cellular RNAs remains poorly understood. Here, we identify a central role for the human DEDD deadenylase TOE1 in distinguishing the fates of small nuclear (sn)RNAs of the spliceosome from unstable genome-encoded snRNA variants. We found that TOE1 promotes maturation of all regular RNA polymerase II transcribed snRNAs of the major and minor spliceosomes by removing posttranscriptional oligo(A) tails, trimming 3' ends, and preventing nuclear exosome targeting. In contrast, TOE1 promotes little to no maturation of tested U1 variant snRNAs, which are instead targeted by the nuclear exosome. These observations suggest that TOE1 is positioned at the center of a 3' end quality control pathway that selectively promotes maturation and stability of regular snRNAs while leaving snRNA variants unprocessed and exposed to degradation in what could be a widespread mechanism of RNA quality control given the large number of noncoding RNAs processed by DEDD deadenylases.

Indexed as

Cell LineCell NucleusGene DeletionHeLa CellsHumansNuclear ProteinsNucleocytoplasmic Transport ProteinsPhosphoproteinsRNA 3' End ProcessingRNA, Small NuclearRNA StabilityNuclear ProteinsNucleocytoplasmic Transport ProteinsPHAX protein, humanPhosphoproteinsRNA, Small NuclearTOE1 protein, humanadenylationCaf1zdeadenylationpontocerebellar hypoplasiasnRNA biogenesissnRNA quality controlTOE1

Identifiers

PMID32499401
PMCPMC7328512
OpenAlexW3034090272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.